Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,337 public trials 2,831 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Active, Not Recruiting

Venetoclax in Addition to Blinatumomab in Adult Patients With Relapsed/Refractory B Cell Precursor Acute Lymphoblastic Leukemia Relapsed/Refractory B Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL)

NCT05182385

Conditions
ALL, Recurrent, Adult, Disease Attributes, Hematologic Diseases, +15 more
Locations
  • Universitätsklinikum Tübingen Tübingen, Baden-Wurttemberg, Germany
  • Universitätsklinikum Ulm Ulm, Baden-Wurttemberg, Germany
  • University Hospital of Frankfurt (Main) Frankfurt am Main, Hesse, Germany
  • Universitätsklinikum Dresden Dresden, Saxony, Germany
View all 17 locations
View Trial Details
Active, Not Recruiting

Ixazomib-pomalidomide-dexamethasone as Second or Third-line Combination Treatment for Patients With Relapsed and Refractory Multiple Myeloma Previously Treated With Daratumumab, Lenalidomide and Bortezomib

NCT04790474

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations
  • Emek Medical Center Afula, Israel
  • Rambam Medical Center Haifa, Israel
  • Hadassah Ein-Kerem Medical Center Jerusalem, Israel
  • Shearei Zedek Medical Center Jerusalem, Israel
View Trial Details
Active, Not Recruiting

Study of Standard Intensive Chemotherapy Versus Intensive Chemotherapy With CPX-351 in Adult Patients With Newly Diagnosed AML and Intermediate- or Adverse Genetics

NCT03897127

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Medizinische Universität Graz Graz, Austria
  • Tirol Kliniken GmbH Innsbruck Innsbruck, Austria
  • Ordensklinikum Linz GmbH, Elisabethinen Linz, Austria
  • Feldkirch, Landeskrankenhaus Rankweil, Austria
View all 62 locations
View Trial Details
Active, Not Recruiting

A Study of Clinical Outcomes in Chronic Lymphocytic Leukemia (CLL) Patients Treated With Venetoclax in Greece

NCT04159779

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • Henry Dunnant Hospital Center /ID# 241682 Athens, Attica, Greece
  • General Hospital of Athens Gennimatas /ID# 212917 Athens, Attica, Greece
  • General Hospital of Athens Laiko /ID# 212902 Athens, Attica, Greece
  • General Hospital of Athens Laiko /ID# 230222 Athens, Attica, Greece
View all 21 locations
View Trial Details
Active, Not Recruiting

Safety and Tolerability Study of Oral ABBV-744 Tablet Alone or in Combination With Oral Ruxolitinib Tablet or Oral Navitoclax Tablet in Adult Participants With Myelofibrosis

NCT04454658

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +4 more
Locations
  • University of California, Davis Comprehensive Cancer Center /ID# 221790 Sacramento, California, United States
  • Duplicate_Dartmouth-Hitchcock Medical Center - 1 Medical Center Drive /ID# 224623 Lebanon, New Hampshire, United States
  • Roswell Park Cancer Institute /ID# 222557 Buffalo, New York, United States
  • The Mount Sinai Hospital /ID# 221549 New York, United States
View all 43 locations
View Trial Details
Active, Not Recruiting

Study of Anti-CD33 Chimeric Antigen Receptor-Expressing T Cells (CD33CART) in Children and Young Adults With Relapsed/Refractory Acute Myeloid Leukemia

NCT03971799

Conditions
Acute Myelogenous Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Children's Hospital of Los Angeles Los Angeles, California, United States
  • Children's Hospital of Colorado Aurora, Colorado, United States
  • National Cancer Institute - NIH Bethesda, Maryland, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details

Related conditions